BridgeMD
New treatment option for Refractive Errors
Official title Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities
ClinicalTrials.gov ID: NCT04077086
What this study is testing
- What it's testing
- Chinese children are some of the most short-sighted in the world, but only one in five children in poor areas who needs glasses has them. Our team has already shown in other trials that giving children free glasses leads to better grades and that free glasses have a bigger impact on grades than factors like parents' education level and the amount of money a family has.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 18
You may be able to join if
- Year 1 classes (likely age 12-13 years) at the recruited schools
- Have uncorrected (without glasses) visual acuity of ≤6/12 in both eyes;
- Refractive error meets cut-offs shown to be associated with significantly greater improvement in visual acuity when corrected (myopia ≤-0.75 diopters...
- Visual acuity can be improved to \>= 6/7.5 in at least one eye with glasses.
You likely can't join if
- Presence of visually-significant ocular condition besides refractive error
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, Liaoning, China
- Yinchuan, Xixia, China
- Belfast, Northern Ireland, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, Liaoning, China; Yinchuan, Xixia, China; Belfast, Northern Ireland, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.